GADD45α mediates arsenite-induced cell apoptotic effect in human hepatoma cells via JNKs/AP-1-dependent pathway

Journal of Cellular Biochemistry

Volumn 109, Issue 6, 2010, Pages 1264-1273

  Gao, Ming ^a   Dong, Wen ^a   Hu, Meiru ^a   Yu, Ming ^a   Guo, Liang ^a   Qian, Lu ^a   Guo, Ning ^a   Song, Lun ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Apoptosis; Arsenite; GADD45 ; Hepatoma

Indexed keywords

ARSENIC TRIOXIDE; CYTOTOXIC AGENT; GADD45ALPHA PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ARSENOUS ACID DERIVATIVE; CELL CYCLE PROTEIN; GADD45A PROTEIN, HUMAN; NUCLEAR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; FLOW CYTOMETRY; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; CELL STRAIN HEPG2; DRUG EFFECT; GENETICS; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; ARSENITES; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; HEP G2 CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 77951721377     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22509     Document Type: Article

References (32)

1. Ashida R, Tominaga K, Sasaki E, Watanabe T, Fujiwara Y, Oshitani N, Higuchi K, Mitsuyama S, Iwao H, Arakawa T. 2005. AP-1 and colorectal cancer. Inflammopharmacology 13:113-125.
2. 3 exerts dose-dependent dual effects on APL cells. Blood 89:3345-3353.
3. Chen F, Lu Y, Zhang Z, Vallyathan V, Ding M, Castranova V, Shi X. 2001. Opposite effect of NF-kappa B and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite. J Biol Chem 276:11414-11419. (Pubitemid 38089335)
4. Darnell JE, Jr. 2002. Transcription factors as targets for cancer therapy. Nat Rev Cancer 2:740-749. (Pubitemid 37328909)
5. Dhanasekaran DN, Reddy EP. 2008. JNK signaling in apoptosis. Oncogene 27:6245-6251.
6. Fayolle C, Pourchet J, de Fromentel CC, Puisieux A, Dore JF, Voeltzel T. 2008. Gadd45a activation protects melanoma cells from ultraviolet B-induced apoptosis. J Invest Dermatol 128:196-202. (Pubitemid 350249379)
7. Ferrer I, Pozas E, Planas AM. 2000. c-Jun/AP-1 (N) expression and apoptosis. Neuroscience 96:447-448.
8. Gao M, Guo N, Song L. 2009. Diverse roles of GADD45a in stress signaling. Curr Protein Pept Sci 10:388-394.
9. Gish RG, Baron A. 2008. Hepatocellular carcinoma (HCC): Current and evolving therapies. IDrugs 11:198-203. (Pubitemid 351323374)
10. Gupta M, Gupta SK, Hoffman B, Liebermann DA. 2006. Gadd45a and Gadd45b protect hematopoietic cells from UV-induced apoptosis via distinct signaling pathways, including p38 activation and JNK inhibition. J Biol Chem 281:17552-17558. (Pubitemid 44035554)
11. Huang C, Ma WY, Li J, Dong Z. 1999. Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway. Cancer Res 59:3053-3058. (Pubitemid 29316000)
12. Ivanov VN, Hei TK. 2004. Arsenite sensitizes human melanomas to apoptosis via tumor necrosis factor alpha-mediated pathway. J Biol Chem 279:22747-22758.
13. Kito M, Akao Y, Ohishi N, Yagi K, Nozawa Y. 2002. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 291:861-867. (Pubitemid 34694354)
14. Levy DE, Darnell JE, Jr. 2002. Stats: Transcriptional control and biological impact. Nat Rev Mol Cell Biol 3:651-662.
15. Li X, Ding X, Adrian TE. 2003. Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation, and GADD expression. Pancreas 27:174-179. (Pubitemid 36950729)
16. Litzow MR. 2008. Arsenic trioxide. Expert Opin Pharmacother 9:1773-1785.
17. Miyake Z, Takekawa M, Ge Q, Saito H. 2007. Activation of MTK1/MEKK4 by GADD45 through induced N-C dissociation and dimerization-mediated trans autophosphorylation of the MTK1 kinase domain. Mol Cell Biol 27:2765-2776. (Pubitemid 46581364)
18. Ora I, Bondesson L, Jonsson C, Ljungberg J, Porn-Ares I, Garwicz S, Pahlman S. 2000. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro. Biochem Biophys Res Commun 277:179-185.
19. Pei B, Wang S, Guo X, Wang J, Yang G, Hang H, Wu L. 2008. Arsenite-induced germline apoptosis through a MAPK-dependent, p53-independent pathway in Caenorhabditis elegans. Chem Res Toxicol 21:1530-1535.
20. Rousselot P, Labaume S, Marolleau JP, Larghero J, Noguera MH, Brouet JC, Fermand JP. 1999. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Cancer Res 59:1041-1048. (Pubitemid 29135964)
21. Ruiz-Ramos R, Lopez-Carrillo L, Rios-Perez AD, De Vizcaya-Ruiz A, Cebrian ME. 2009. Sodium arsenite induces ROS generation, DNA oxidative damage, HO-1 and c-Myc proteins, NF-kappaB activation and cell proliferation in human breast cancer MCF-7 cells. Mutat Res 674:109-115.
22. Song L, Li J, Zhang D, Liu ZG, Ye J, Zhan Q, Shen HM, Whiteman M, Huang C. 2006. IKKbeta programs to turn on the GADD45alpha-MKK4-JNK apoptotic cascade specifically via p50 NF-kappaB in arsenite response. J Cell Biol 175:607-617. (Pubitemid 44790614)
23. Song L, Li J, Hu M, Huang C. 2008. Both IKKalpha and IKKbeta are implicated in the arsenite-induced AP-1 transactivation correlating with cell apoptosis through NF-kappaB activity-independent manner. Exp Cell Res 314:2187-2198.
24. Taylor BF, McNeely SC, Miller HL, Lehmann GM, McCabe MJ, Jr., States JC. 2006. p53 suppression of arsenite-induced mitotic catastrophe is mediated by p21CIP1/WAF1. J Pharmacol Exp Ther 318:142-151. (Pubitemid 43920751)
25. Uslu R, Sanli UA, Sezgin C, Karabulut B, Terzioglu E, Omay SB, Goker E. 2000. Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clin Cancer Res 6:4957-4964. (Pubitemid 32110442)
26. Vial E, Marshall CJ. 2003. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J Cell Sci 116:4957-4963. (Pubitemid 38016702)
27. Yamasawa K, Nio Y, Dong M, Yamaguchi K, Itakura M. 2002. Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer. Clin Cancer Res 8:2563-2569. (Pubitemid 34856340)
28. Zhan Q. 2005. Gadd45a, a p53- and BRCA1-regulated stress protein, in cellular response to DNA damage. Mutat Res 569:133-143. (Pubitemid 39643263)
29. Zhang TC, Cao EH, Li JF, Ma W, Qin JF. 1999. Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide. Eur J Cancer 35:1258-1263. (Pubitemid 29359187)
30. Zhang TD, Chen GQ, Wang ZG, Wang ZY, Chen SJ, Chen Z. 2001. Arsenic trioxide, a therapeutic agent for APL. Oncogene 20:7146-7153. (Pubitemid 33105004)
31. Zhang T, Wang SS, Hong L, Wang XL, Qi QH. 2003. Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo. J Exp Clin Cancer Res 22:61-68. (Pubitemid 36396659)
32. Zhang D, Song L, Li J, Wu K, Huang C. 2006. Coordination of JNK1 and JNK2 is critical for GADD45alpha induction and its mediated cell apoptosis in arsenite responses. J Biol Chem 281:34113-34123. (Pubitemid 46036620)